Likun Huang

Likun Huang

Auto-generated profile, based on publicly available information

Likun Huang

Fujian Key Laboratory of Crop Breeding by Design, Key Laboratory of Genetics, Breeding and Multiple Utilization of Crops, Ministry of Education, Fujian Agriculture and Forestry University, Fuzhou 350028, Fujian

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2021 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
ZXZhaowei Xu
Zhaowei Xu
YLYang Li
Yang Li
QLQing Lei
Qing Lei
LHLikun Huang
Likun Huang
DLDan-Yun Lai
Dan-Yun Lai
Shengce TaoShengce Tao
Shengce Tao
Coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2, varies with regard to symptoms and mortality rates among populations. Humoral immunity plays critical roles in SARS-CoV-2 infection and recovery from COVID-19. However, differences in immune responses and clinical features among COVID-19 patients remain largely unknown. Here, we report a database for COVID-19-specific IgG/IgM immune responses and clinical parameters (named COVID-ONE-hi). COVID-ONE-hi is based on the data that contain the IgG/IgM responses to 24 full-length/truncated proteins corresponding to 20 of 28 known SARS-CoV-2 proteins and 199 spike protein peptides against 2360 serum samples collected from 783 COVID-19 patients. In addition, 96 clinical parameters for the 2360 serum samples and basic information for the 783 patients are integrated into the database. Furthermore, COVID-ONE-hi provides a dashboard for defining samples and a one-click analysis pipeline for a single group or paired groups. A set of samples of interest is easily defined by adjusting the scale bars of a variety of parameters. After the “START” button is clicked, one can readily obtain a comprehensive analysis report for further interpretation. COVID-ONE-hi is freely available at www.COVID-ONE.cn.

30 July 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
ZXZhaowei Xu
Zhaowei Xu
YLYang Li
Yang Li
QLQing Lei
Qing Lei
LHLikun Huang
Likun Huang
DLDan-Yun Lai
Dan-Yun Lai
Shengce TaoShengce Tao
Shengce Tao
Coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2, varies with regard to symptoms and mortality rates among populations. Humoral immunity plays critical roles in SARS-CoV-2 infection and recovery from COVID-19. However, differences in immune responses and clinical features among COVID-19 patients remain largely unknown. Here, we report a database for COVID-19-specific IgG/IgM immune responses and clinical parameters (COVID-ONE humoral immune). COVID-ONE humoral immunity is based on a dataset that contains the IgG/IgM responses to 21 of 28 known SARS-CoV-2 proteins and 197 spike protein peptides against 2,360 COVID-19 samples collected from 783 patients. In addition, 96 clinical parameters for the 2,360 samples and information for the 783 patients are integrated into the database. Furthermore, COVID-ONE humoral immune provides a dashboard for defining samples and a one-click analysis pipeline for a single group or paired groups. A set of samples of interest is easily defined by adjusting the scale bars of a variety of parameters. After the “START” button is clicked, one can readily obtain a comprehensive analysis report for further interpretation. COVID-ONE-humoral immune is freely available at www.COVID-ONE.cn .

4 August 2025 in Plant Physiology
Verified
Journal Article
Open access
HGHuazhong Guan
Huazhong Guan
ZCZhiwei Chen
Zhiwei Chen
SWShuoxun Wang
Shuoxun Wang
BJBo Jiang
Bo Jiang
JZJinxiang Zhao
Jinxiang Zhao
KWKun Wu
Kun Wu
A new elite allele conferring enhanced preharvest sprouting resistance via hormonal pathways is a valuable target for molecular design breeding to improve seed quality and production stability.

1 August 2021 in medRxiv
Verified
Preprint
Open access
PDF file
ZXZhaowei Xu
Zhaowei Xu
YLYang Li
Yang Li
QLQing Lei
Qing Lei
LHLikun Huang
Likun Huang
DLDan-Yun Lai
Dan-Yun Lai
Shengce TaoShengce Tao
Shengce Tao
Coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2, varies with regard to symptoms and mortality rates among populations. Humoral immunity plays critical roles in SARS-CoV-2 infection and recovery from COVID-19. However, differences in immune responses and clinical features among COVID-19 patients remain largely unknown. Here, we report a database for COVID-19-specific IgG/IgM immune responses and clinical parameters (COVID-ONE humoral immune). COVID-ONE humoral immunity is based on a dataset that contains the IgG/IgM responses to 21 of 28 known SARS-CoV-2 proteins and 197 spike protein peptides against 2,360 COVID-19 samples collected from 783 patients. In addition, 96 clinical parameters for the 2,360 samples and information for the 783 patients are integrated into the database. Furthermore, COVID-ONE humoral immune provides a dashboard for defining samples and a one-click analysis pipeline for a single group or paired groups. A set of samples of interest is easily defined by adjusting the scale bars of a variety of parameters. After the “START” button is clicked, one can readily obtain a comprehensive analysis report for further interpretation. COVID-ONE-humoral immune is freely available at www.COVID-ONE.cn .